Science Reference

Hodgkin's lymphoma

Hodgkin's lymphoma, formerly known as Hodgkin's disease, is a type of lymphoma first described by Thomas Hodgkin in 1832.

Hodgkin's lymphoma is characterized clinically by the orderly spread of disease from one lymph node group to another and by the development of systemic symptoms with advanced disease.

Pathologically, the disease is characterized by the presence of Reed-Sternberg cells.

Swollen but painless lymph nodes are the most common sign of Hodgkin's lymphoma, often occurring in the neck.

The lymph nodes of the chest are often affected and these may be noticed on a chest X-ray.

Hodgkin's lymphoma was one of the first cancers to be rendered curable by combination chemotherapy.

Currently, the ABVD chemotherapy regimen is the gold standard for treatment of Hodgkin's disease.

With appropriate treatment, over 85% of Hodgkin's lymphoma cases are curable..

For more information about the topic Hodgkin's lymphoma, read the full article at Wikipedia.org, or see the following related articles:

Note: This page refers to an article that is licensed under the GNU Free Documentation License. It uses material from the article Hodgkin's lymphoma at Wikipedia.org. See the Wikipedia copyright page for more details.

Search ScienceDaily

Number of stories in archives: 44,032

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.
 

Science Video News


Diagnosing Alzheimer's Early

A new brain-imaging method allows physicians to diagnose Alzheimer's before its onset. A radioactive dye is injected in the blood and travels to the. ...  > full story

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of the new ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Email this page's link to a friend or colleague:
close